» Articles » PMID: 16840344

Effective Suppression of Human Immunodeficiency Virus Type 1 Through a Combination of Short- or Long-hairpin RNAs Targeting Essential Sequences for Retroviral Integration

Overview
Journal J Virol
Date 2006 Jul 15
PMID 16840344
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Small interfering RNA (siRNA) could provide a new therapeutic approach to treating human immunodeficiency virus type 1 (HIV-1) infection. For long-term suppression of HIV-1, emergence of siRNA escape variants must be controlled. Here, we constructed lentiviral vectors encoding short-hairpin RNAs (shRNA) corresponding to conserved target sequences within the integrase (int) and the attachment site (att) genes, both of which are essential for HIV-1 integration. Compared to shRNA targeting of the HIV-1 transcription factor tat (shTat), shRNA against int (shIN) or the U3 region of att (shU3) showed a more potent inhibitory effect on HIV-1 replication in human CD4+ T cells. Infection with a high dose of HIV-1 resulted in the emergence of escape mutants during long-term culture. Of note, limited genetic variation was observed in the viruses resistant to shIN. A combination of shINs against wild-type and escape mutant sequences had a negative effect on their antiviral activities, indicating a potentially detrimental effect when administering multiple shRNA targeting the same region to combat HIV-1 variants. The combination of shIN and shU3 att exhibited the strongest anti-HIV-1 activity, as seen by complete abrogation of viral DNA synthesis and viral integration. In addition, a modified long-hairpin RNA spanning the 50 nucleotides in the shIN target region effectively suppressed wild-type and shIN-resistant mutant HIV-1. These results suggest that targeting of incoming viral RNA before proviral DNA formation occurs through the use of nonoverlapping multiple siRNAs is a potent approach to achieving sustained, efficient suppression of highly mutable viruses, such as HIV-1.

Citing Articles

A Recombinant Lentiviral Vegfr2-Silencing Vector Attenuates Roxarsone-Promoted Growth of Rat Vascular Endothelial Cells and Angiogenesis in Matrigel Plug and B16F10 Xenograft Models.

Chen X, Chen L, Chen B, Wei Q, Wu Y, Zhang Y Vet Sci. 2024; 11(10).

PMID: 39453043 PMC: 11511396. DOI: 10.3390/vetsci11100451.


Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges.

Kang H, Ga Y, Kim S, Cho Y, Kim J, Kim C J Biomed Sci. 2023; 30(1):88.

PMID: 37845731 PMC: 10577957. DOI: 10.1186/s12929-023-00981-9.


Winning the Tug-of-War Between Effector Gene Design and Pathogen Evolution in Vector Population Replacement Strategies.

Marshall J, Raban R, Kandul N, Edula J, Leon T, Akbari O Front Genet. 2019; 10:1072.

PMID: 31737050 PMC: 6831721. DOI: 10.3389/fgene.2019.01072.


Multi-targeting of viral RNAs with synthetic trans-acting small interfering RNAs enhances plant antiviral resistance.

Carbonell A, Lison P, Daros J Plant J. 2019; 100(4):720-737.

PMID: 31350772 PMC: 6899541. DOI: 10.1111/tpj.14466.


The therapeutic landscape of HIV-1 via genome editing.

Kwarteng A, Ahuno S, Kwakye-Nuako G AIDS Res Ther. 2017; 14(1):32.

PMID: 28705213 PMC: 5513397. DOI: 10.1186/s12981-017-0157-8.


References
1.
Boden D, Pusch O, Lee F, Tucker L, Shank P, Ramratnam B . Promoter choice affects the potency of HIV-1 specific RNA interference. Nucleic Acids Res. 2003; 31(17):5033-8. PMC: 212804. DOI: 10.1093/nar/gkg704. View

2.
Matsumoto S, Miyagishi M, Akashi H, Nagai R, Taira K . Analysis of double-stranded RNA-induced apoptosis pathways using interferon-response noninducible small interfering RNA expression vector library. J Biol Chem. 2005; 280(27):25687-96. DOI: 10.1074/jbc.M412784200. View

3.
Bennasser Y, Le S, Benkirane M, Jeang K . Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity. 2005; 22(5):607-19. DOI: 10.1016/j.immuni.2005.03.010. View

4.
Anderson J, Akkina R . CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection. Retrovirology. 2005; 2:53. PMC: 1199620. DOI: 10.1186/1742-4690-2-53. View

5.
Lee N, Dohjima T, Bauer G, Li H, Li M, Ehsani A . Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol. 2002; 20(5):500-5. DOI: 10.1038/nbt0502-500. View